- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- The ReproPsych Group
- CAS Newsletter
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
2013 FACE meeting
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting .
- Read more in our News Archive
Current Studies at Motherisk
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Nausea/Vomiting and Treatment
J Obstet Gynaecol. 2004 Aug;24(5):530-3.
Koren G, Maltepe C: Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum.
Birth Defects Res A Clin Mol Teratol. 2004 Aug;70(8):528-30.
Boskovic R, Rudic N, Danieliewska-Nikiel B, Navioz Y, Koren G: Is lack of morning sickness teratogenic? A prospective controlled study.
Am J Obstet Gynecol. 2003 Nov;189(5):1374-7.
Portnoi G et al: Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy.
J Psychosom Obstet Gynaecol 22: 7-12, 2001.
Mazzotta P, Stewart DE, Koren G, Magee LA: Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy.
J Psychosom Obstet Gynaecol. 24: 71-5, 2003.
Chandra K, Magee L, Einarson A, Koren G: Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms.
J Obstet Gynaecol Can. 25: 830-3, 2003.
Boskovic R, Einarson A, Maltepe C, Wolpin J, Koren G: Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing.
Crit Care Med. 2002 Aug;30(8):1883-92.
von Dadelszen P et al: Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity?
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S256-61.
Magee LA, Mazzotta P, Koren G: Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S248-52
Koren G, Levichek Z: The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk.
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S232-8.
Magee LA, Chandra K, Mazzotta P, Stewart D, Koren G, Guyatt GH: Development of a health-related quality of life instrument for nausea and vomiting of pregnancy.
Am J Obstet Gynecol. 2002 May;185(5 Suppl Understanding):S228-31.
Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A: Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy.
J Clin Pharmacol 2001 Aug;41(8):842-5
Atanackovic G, Navioz Y, Moretti ME, Koren G: The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.
Ann Pharmacother. 2000 Dec;34(12):1486-7. No abstract available.
Einarson A, Levichek Z, Einarson TR, Koren G: The antiemetic effect of cetirizine during pregnancy.
Eur J Obstet Gynecol Reprod Biol. 2001 Jan;94(1):31-36.
Koren G, Magee L, Attard C, Kohli M, Atanackovic G, Bishai R, Chandra K, Navioz Y, Maltepe C: A novel method for the evaluation of the severity of nausea and vomiting of pregnancy
Can J Clin Pharmacol. 2000 Winter;7(4):205-8.
Lee J, Einarson A, Gallo M, Okotore B, Koren G: Longitudinal change in the treatment of nausea and vomiting of pregnancy in ontario.
J Psychosom Obstet Gynaecol. 2000 Sep;21(3):129-36.
Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee LA: Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy.
Can J Clin Pharmacol. 2000 Autumn;7(3):138-43.
Bishai R, Mazzotta P, Atanackovic G, Levichek Z, Pole M, Magee LA, Koren G: Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).
Int J Gynaecol Obstet. 2000 Sep;70(3):359-65.
Mazzotta P, Maltepe C, Navioz Y, Magee LA, Koren G: Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada.
Clin Invest Med. 1999 Jun;22(3):106-10
Emelianova S, Mazzotta P, Einarson A, Koren G: Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation.
Eur J Obstet Gynecol Reprod Biol. 1998 Jan;76(1):1-3. Review. No abstract available.
Einarson A, Koren G, Bergman U: Nausea and vomiting in pregnancy: a comparative European study.
Reprod Toxicol 9: 1-6, 1995. No abstract available.
Ornstein M, Einarson A, Koren G: Bendectin/Diclectin for morning sickness; A Canadian follow-up of an American tragedy.
Koren G: Drug of choice for morning sickness. Can Fam Physicians, 41: 1671-1674, 1995.